Pseudomonas aeruginosa in Chronic Suppurative Otitis Media

Artono Artono1, Nyilo Purnami2, Edi Handoko3

  • 1Doctoral Program, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.

PubMed
Abstract

Insights

Pseudomonas aeruginosa is a common cause of chronic suppurative otitis media (CSOM). Acetic acid effectively inhibits and eradicates P. aeruginosa biofilms, offering a potential treatment strategy for CSOM.

Area of Science:

  • Otolaryngology
  • Microbiology
  • Infectious Diseases

Background:

  • Chronic suppurative otitis media (CSOM) is a significant cause of hearing impairment in developing nations.
  • Rising antibiotic resistance is linked to inappropriate antibiotic use.
  • Biofilm-forming bacteria, particularly Pseudomonas aeruginosa, are frequently implicated in CSOM, leading to poorer patient outcomes.

Purpose of the Study:

  • To characterize the bacterial profile in CSOM patients.
  • To assess antibiotic susceptibility patterns.
  • To evaluate the antibiofilm efficacy of acetic acid against Pseudomonas aeruginosa.

Main Methods:

  • Bacterial isolation and identification from CSOM patient samples.
  • Antibiotic susceptibility testing using the Kirby Bauer disc diffusion method.
  • In vitro assessment of acetic acid's antibiofilm activity (MBIC and MBEC) via microtiter plate assays.

Main Results:

  • Pseudomonas aeruginosa was the predominant Gram-negative bacterium identified in 31 of 45 CSOM samples.
  • High susceptibility rates (93.33%) were observed for meropenem, amikacin, piperacillin-tazobactam, ceftazidime, and cefoperazone-sulbactam.
  • Acetic acid demonstrated significant antibiofilm activity, with a Minimum Biofilm Inhibitory Concentration (MBIC) of 0.16% and a Minimum Biofilm Eradication Concentration (MBEC) of 0.31%.

Conclusions:

  • P. aeruginosa is a prevalent pathogen in CSOM, exhibiting sensitivity to specific antibiotics including meropenem and amikacin.
  • Acetic acid effectively inhibits P. aeruginosa biofilm formation at 0.16% and eradicates biofilms at 0.31%.
  • Acetic acid presents a promising therapeutic agent for managing P. aeruginosa biofilms in CSOM.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24